Skip to main content
. Author manuscript; available in PMC: 2013 Mar 7.
Published in final edited form as: Clin Neuropsychol. 2012 Mar 7;26(2):288–304. doi: 10.1080/13854046.2011.653404

Table 2.

CVLT-II Performance in the Three Study Samples (n = 186)

CVLT-II Variables HIV− (n = 43) HIV+ HAND− (n = 103) HIV+ HAND+ (n = 40) pa db (HIV− vs HAND+) db (HAND− vs HAND+)
Item Specific Deficit Indices
 Encoding Index 4.0 (2.0, 6.0) 5.0 (3.0, 7.0) 7.0 (5.0, 9.0) .0024 −0.79 −0.49
 Consolidation Index 0.1 (0.1, 0.2) 0.1 (0.1, 0.3) 0.2 (0.1, 0.3) .0368 −0.55 −0.37
 Retrieval Index 0.4 (0.3, 0.6) 0.4 (0.2, 0.6) 0.6 (0.5, 0.7) .0005 −0.64 −0.73
Standard Indices (raw)
 Trials 1–5 56.0 (46.0, 62.0) 49.0 (41.0, 59.0) 44.0 (40.0, 51.8) .0045 0.77 0.44
 Short Delay Free Recall 11.0 (9.0, 14.0) 11.0 (8.0, 13.3) 9.0 (6.0, 10.0) .0006 0.94 0.63
 Long Delay Free Recall 12.0 (9.0, 14.0) 11.0 (8.0, 14.0) 9.0 (5.3, 11.0) .0010 0.89 0.58
 Total Recognition (d′) 3.1 (2.6, 3.7) 3.3 (2.5, 3.8) 2.7 (2.1, 3.3) .0085 0.61 0.48
Semantic Clustering 0.9 (0.2, 2.6) 1.0 (−0.2, 3.5) 0.1 (−0.3, 1.0) .0147 0.52 0.55
Recall Consistency 85.0 (79.0, 92.0) 83.0 (76.0, 90.0) 78.5 (73.0, 83.0) .0007 0.82 0.59
SDFR vs. Trial 5 −10.0 (−27.3, 0.0) −11.8 (−30.8, 0.0) −23.1 (−30.6, −13.0) .0063 0.69 0.49
LDFR vs. Trial 5 −6.7 (−18.8, 0.0) −8.3 (−25.6, 0.0) −20.7 (−37.2, −9.1) .0105 0.68 0.45
Total Recog Disc vs. LDFR 33.3 (14.8, 55.0) 37.0 (17.6, 65.9) 55.6 (26.5, 90.7) .0548 −0.32 −0.30

Note. Data represent medians and interquartile ranges.

a

In all significant pairwise comparisons, HIV− = HAND− > HAND+

b

bias corrected Hedges d effect size estimate.